期刊文献+

中国人遗传性非息肉病性结直肠癌hMLH1与hMSH2基因的种系突变研究 被引量:14

Study of germline mutation of hMLH1 and hMSH2 in Chinese kindreds of hereditary nonpolyposis colorectal cancer
原文传递
导出
摘要 目的探讨中国人遗传性非息肉病性结直肠癌(HNPCC)患者hMLH1与hMSH2基因的种系突变特点。方法对诊治的6个HNPCC家系的先证者用聚合酶链反应(PCR)的方法扩增其hMLH1及hMSH2的35个外显子,SSCP方法检测其变异,对可疑突变者进行自动测序以确定突变类型。结果6例先证者SSCP检测在3例患者中发现4处异常条带,自动测序证实hMSH211外显子有1处插入突变和1处错义突变、13外显子有1处错义突变,1例在hMLH118外显子及hMSH215外显子均有插入突变。结论中国人HNPCC的错配修复基因突变以hMSH2为主,插入造成的移码突变和错义突变仍为主要病理突变类型。 Objective To analysis the features of the germline mutation of hMLH 1 and hMSH 2 in Chinese kindreds of hereditary nonpolyposis colorectal cancer (HNPCC). Method Thirty five exons in hMLH 1 and hMSH 2 of the index cases in 6 chinese HNPCC kindreds were amplified by PCR and their abnormalities were analyzed by SSCP, then the mutation type was determined with automatic sequencer. Results Four abnormal strap were found in 3 of above 6 cases by SSCP. Sequencing showed that exon 11 of hMLH 2 had a insert and a missense mutation and exon 13 had a missense mutation. Another case had insert mutation at exon18 of hMLH 1 and exon 15 of hMSH 2. Conclusions Germline mutation of hMSH 2 dominates in the mutation of the MMR among Chinese HNPCCs. Insertion and missense are main pathogenic mutation.
出处 《中华胃肠外科杂志》 CAS 2002年第2期126-129,共4页 Chinese Journal of Gastrointestinal Surgery
基金 国家自然科学基金资助项目(39970823)
关键词 遗传性非息肉病性结肠直肠肿瘤 基因突变 错配修复 种系突变 分子遗传学 Hereditary nonpolyposis colorectal neoplasm Gene Mutation Mismatch repair
  • 相关文献

参考文献11

  • 1Lynch HT. Hereditary nonpolyposis colorectal cancer. Cytogenet Cell Genet, 1999,86:2.
  • 2Vasen HF, Mecklin JP, Khan PM, et al. The international collaborative group on hereditary nonpolyposis colorectal cancer(ICG-HNPCC). Dis Colon Rectum, 1991,34:34-42.
  • 3Nystom LM, Parsons JP, Sistonen KP, et al. Mismatch repair genes on chromosome 2p and 3p account for a major share of hereditary nonpolyposis colorecta cancer fmilies evaluable by linkage. Am J Hum Genet, 1994, 55: 659-665.
  • 4Planck M, Koul A, Fernebro E, et al.hMLH1,hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from southern Sweden.Int J Cancer, 1999, 83: 197-202.
  • 5Vasen HF, Wijvnen JT, Menko FH, et al.Cancer risk in families with hereditary nonpolyposis colorectal cancer diagonosed by mutation analysis. Gastroenterology, 1996,110:1020-1027.
  • 6Wijnen J, Vasen H, Khan PM,et al.Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet,1995,56:1060-1066.
  • 7Beck NE, Tomlinson IPM, Homfray T, et al. Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria.Hum Genet, 1997,99:219-224.
  • 8袁瑛,郑树.可疑遗传性非息肉病性结直肠癌的hMLH1和hMSH2基因突变研究[J].中华医学杂志,1999,79(5):346-348. 被引量:25
  • 9Han HJ, Yuan Y, Ku JL, et al. Germline mutation of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst, 1996, 88: 1317-1319.
  • 10Fidalgo P, Almeida MR, West S, et al.Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer(HNPCC)by a multi-method approch. Eur J Hum Genet,2000,8:49-53.

二级参考文献9

  • 1Han H J,J Natl Cancer Inst,1996年,88卷,1317页
  • 2Liu B,Nature Med,1996年,2卷,169页
  • 3Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum . In: Hamilton SR, Aaltonen L, eds. Pathalogy and genetics of tumors of the digestive system. World Health Organization classification of tumors, Lyon(France): Impress, 2001. 105-119.
  • 4Vogelstein B, Lane D, Levine AJ. Surfing the P53 network. Nature,2000, 408: 307-310.
  • 5Staib L, Schirrmeister H, Reseke SN, et al. Is(18) Ffluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg, 2000.180:1-5.
  • 6Whiteford MH, Whiteferd HM. Yee LF, et al. Usefulness of FDG-PET sean in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum, 2000, 43: 759-770.
  • 7Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol. 1997, 4: 613-620.
  • 8Schiepers C, Penninckx F, De Vadder N. et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol. 1995.21: 517-522.
  • 9Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst, 1996. 88: 838-839.

共引文献30

同被引文献75

引证文献14

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部